Clinical Trial Update: The Effect of Monoallelic Variants in the ALPL Gene on the Natural Course of Hypophosphatasia in Russia

View source ↗

Summary

AstraZeneca is conducting a clinical trial in Russia to assess how monoallelic ALPL gene variants affect the natural course of hypophosphatasia, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypophosphatasia

Snippet

Sponsor: AstraZeneca | Conditions: Hypophosphatasia | Status: RECRUITING